Details of Disease

Disease Name

Immune thrombocytopenic purpura

Disease Class

3B64: Thrombocytopenia

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISYJ8IL: Immune thrombocytopenic purpura

ICD-11

ICD-11: 3B64.13

ICD-10

ICD-10: D69

ICD-9

ICD-9: 287.31

Expand ICD-11

3B64.10

Expand ICD-10

D69

Expand ICD-9

287.31

Disease Identifiers

MONDO ID

MONDO_0008558

MESH ID

D016553

UMLS CUI

C0398650

OMIM ID

188030

MedGen ID

584986

Orphanet ID

3002

General Information of Disease (ID: DISYJ8IL)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Fostamatinib	DM6AUHV	Approved	Small molecular drug	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
A157	DMFP4FX	IND submitted	Fusion protein	[2]
LGD-4665	DM9T8A2	Phase 2	NA	[3]
PF-06835375	DMNIYPS	Phase 2	NA	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
2	Clinical pipeline report, company report or official report of Klus Pharma
3	Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54.
4	ClinicalTrials.gov (NCT05070845) AN INTERVENTIONAL PHASE 2, OPEN-LABEL, MULTI-CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMBOCYTOPENIA. U.S.National Institutes of Health.